San Francisco, CA, August 30, 2013 (PRWEB) 2013
Redbiotec and TeselaGen have announced a joint venture to build a scalable, integrated, rapid design and rapid prototyping infrastructure for the creation of a library for Herpesvirus vaccine development. This library will enable new concepts for vaccines against Herpesviruses and will enable the optimization and improvement of new and existing vaccine candidates. Read more: Redbiotec and Teselagen to partner.